SCHEMBL1033689

SCHEMBL1033689

CCCNCCOc1ccc(NS(=O)(=O)c2ccc(OCCF)cc2)c(C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.43
MAPT P10636 2/20 0.42
KDM4E B2RXH2 2/20 0.42
LMNA P02545 6/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
HTT P42858 4/20 0.41
TSHR P16473 3/20 0.41
SQSTM1 Q13501 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TP53 P04637 1/20 0.39
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
MMP13 P45452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4251154 0.99 PKM (0.42) PKMMAPTKDM4ELMNASMN1; SMN2
SCHEMBL1032791 0.88 TSHR (0.44) PKMMAPTKDM4ELMNASMN1; SMN2
SCHEMBL1033616 0.88 PKM (0.39) PKMMAPTKDM4ELMNASMN1; SMN2
SCHEMBL1033640 0.88 PKM (0.39) PKMMAPTKDM4ELMNASMN1; SMN2
Hydrochloric Acid SCHEMBL4240512 0.87 PKM (0.39) PKMMAPTKDM4ELMNASMN1; SMN2
Hydrochloric Acid SCHEMBL4245486 0.87 TSHR (0.44) PKMMAPTKDM4ELMNASMN1; SMN2
Hydrochloric Acid SCHEMBL4244176 0.87 PKM (0.39) PKMMAPTKDM4ELMNASMN1; SMN2
SCHEMBL1029498 0.87 KIT (0.41) PKMMAPTKDM4ELMNASMN1; SMN2
SCHEMBL1031574 0.87 CCR9 (0.44) PKMMAPTKDM4ESQSTM1KEAP1
SCHEMBL1031405 0.86 KDM4E (0.39) MAPTKDM4ELMNASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013179-B1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO KG (DE) 2011-01-19 EP disclosed
EP-2013179-A1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR Abbott GmbH & Co. KG (DE) 2009-01-14 EP disclosed
WO-2007118859-A1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2007-10-25 WO disclosed